Would I Lie to You?

This week, President Trump welcomed China’s president Xi Jinping to Washington, D.C. for a two-day summit. Knox Thames joins to discuss Chinese religious liberty violations and why the two world leaders will most likely avoid the issue. Then, President Trump signed an agreement w ...  Show more

In June, the FDA authorized the nicotine pouch brand Zyn to advertise themselves as a lower-risk option than cigarettes. With Zyn has been growing in popularity with younger folks, it threatens to become a gateway into nicotine addiction. Luke Simon joins Russell Moore and Claris ...  Show more

Ozempic and other new weight loss drugs are being touted as potential miracle cures for diabetes and obesity. Journalist Johann Hari experimented with the drug and dropped 40 pounds. In his new book, Magic Pill, Hari discusses his experience with Ozempic and speaks to many of the ...  Show more

In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. ...

This week, I’m joined by Johann Hari, New York Times bestselling author, journalist, and speaker, to explore his journey into the world of the new weight loss drug phenomenon: Ozempic. Johann shares his surprising firsthand experience injecting himself weekly with the drug for ov ...  Show more

Ozempic. It started with a lizard, and then transformed into a drug that, depending on who you ask, is either a miracle or the downfall of society. New Yorker writer and cultural critic Jia Tolentino joins Trevor and Christiana to give context on the media circus surrounding w ...